New method shows promise for treating DVT

01/23/2013 | CardiovascularBusiness.com

Treating deep venous thrombosis with anti-clotting drugs that are delivered directly through a catheter to sites with thromboli dissolved the clots in 95% of cases and prevented rethrombosis in most patients, according to a study presented at an endovascular therapy meeting. The rate of bleeding complications was similar to that of standard DVT therapy. A larger study is being prepared to test the new treatment further, with results expected in 2016 or 2017.

View Full Article in:

CardiovascularBusiness.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD